Esophageal Cancer Clinical Trial

Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

Summary

Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.

View Full Description

Full Description

Questionnaires will be answered daily on a weekly basis during period of radiation and chemotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Concurrent radiation and chemotherapy treatment
Aerodigestive malignancy

Exclusion Criteria:

Other causes of vomiting (i.e.gastrointestinal obstruction...)

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

40

Study ID:

NCT00716157

Recruitment Status:

Completed

Sponsor:

Thomas Jefferson University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

40

Study ID:

NCT00716157

Recruitment Status:

Completed

Sponsor:


Thomas Jefferson University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider